Worth Venture Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-143,676
Closed -$626K 148
2020
Q2
$626K Sell
143,676
-1,874
-1% -$8.42K 0.31% 50
2020
Q1
$551K Buy
145,550
+12,500
+9% +$61.4K 0.34% 42
2019
Q4
$841K Sell
133,050
-24,978
-16% -$147K 0.41% 32
2019
Q3
$666K Buy
+158,028
New +$675K 0.38% 36
2019
Q1
Sell
-204,256
Closed -$754K 126
2018
Q4
$754K Buy
204,256
+134,256
+192% +$472K 0.57% 34
2018
Q3
$167K Buy
+70,000
New +$196K 0.13% 76

Other funds holding BDSI

Worth Venture Partners's BDSI Position: Q3 2020 in Review

Worth Venture Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 143,676 shares — an estimated $626K sold.

Worth Venture Partners first reported a position in BDSI in Q3 2018 and held it in 6 quarters. The position peaked at $841K in Q4 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • Worth Venture Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • Worth Venture Partners sold 143,676 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $626K.
  • Worth Venture Partners first reported a position in BioDelivery Sciences International, Inc. in Q3 2018 and held it in 6 quarters.
  • Worth Venture Partners's BioDelivery Sciences International, Inc. position peaked at $841K in Q4 2019.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.